Is Credo Technology Still a Buy After 55% Gain in the Past 6 Months?

Credo Technology (CRDO) has outpaced its sector with a ~54.5% six‑month gain driven by strong demand for its Active Electrical Cables (AECs) in AI data‑center networking and expanding IC wins; management reported non‑GAAP gross margin of 67.7% (up 410 bps) and non‑GAAP operating income of $124.1M versus $8.3M a year ago. The company ended Nov. 1, 2025 with $813.6M in cash and short‑term investments (up from $479.6M on Aug. 2, 2025), sees fiscal Q3 revenue of $335–$345M (≈27% sequential growth at midpoint) and expects >170% YoY revenue growth in fiscal 2026 with net income to more than quadruple. Valuation is rich (forward P/S 17.22 vs sector 8.58) and competition from Broadcom, Marvell and Astera Labs is a material risk, but expanding hyperscaler wins, new product pillars and improved margins underpin a constructive long‑term thesis.

Analysis

Market structure: Credo (CRDO) is the immediate beneficiary as AECs displace optical for sub-7m rack links — this shifts revenue from optical transceiver vendors to SerDes/IC specialists and hyperscalers that lower rack-to-rack power/TCO. Expect pricing power in the near term as hyperscalers standardize on AECs, but capacity and test/assembly constraints could cap upside if demand outpaces supply over 1–2 quarters.

Risk assessment: Key risks are customer concentration (four hyperscalers >10% revenue each, a 5th ramping) and competition from Broadcom (AVGO), Marvell (MRVL) and ALAB; a hyperscaler capex pause or a tech pivot back to optics would be catastrophic. Tail scenarios: a 30–50% sell-off if CRDO misses FY26 retimer revenue ramp or if gross margins compress >500bps; monitor quarterly margin delta and backlog changes within 30–90 days.

Trade implications: Tactical allocation: favor a barbell of equity and option exposure — small core long equity (2–3% portfolio) plus asymmetric options (12–18 month calls) to capture FY26 upside while limiting drawdown. Relative-value: pair long CRDO vs short ALAB (size 1:0.5) to exploit ALAB’s 100% run and higher P/S, and consider taking profits or hedging if CRDO P/S >20 or gross margin slips below 62%.

Contrarian angles: The market may be underpricing supplier concentration and margin cyclicality; P/S 17.2 already embeds accelerated FY26 growth. Historical parallel: Inphi/Intersil adoption cycles showed fast initial pricing power then rapid margin normalization as incumbents integrated solutions — if Broadcom/Marvell vertically integrate retimers/AECS, CRDO’s premium could compress sharply within 12–24 months.

Key Decisions for Investors

• Establish a 2–3% long position in CRDO within the next 5 trading days (capital-weighted). Target 40–60% upside over 12 months; place a protective stop-loss at 20% below entry OR if non-GAAP gross margin drops below 62% on a quarterly report.
• Buy 12–18 month call options on CRDO (LEAPS, expiry Jan–Jun 2027) sized to equal ~1.5% portfolio notional (delta-adjusted). Buy ATM or up to 15% OTM strikes to capture FY26 revenue acceleration; if position gains 50% sell 30% to de-risk and consider selling 2–3 month covered calls against the remaining lot.
• Enter a pair trade: long CRDO (1% portfolio) vs short Astera Labs (ALAB) at 0.5% notional (1:0.5 sizing) to exploit relative fundamentals and P/S dispersion. Close/trim if ALAB outperforms by >30% or if CRDO misses quarterly revenue guide by >5%.
• Trim or avoid pure-play optical transceiver/component names by 1–2% portfolio weight and redeploy into semiconductor/AEC-exposed names (CRDO, select SerDes suppliers). Monitor within 30–60 days: hyperscaler revenue concentration disclosures, backlog trends, and any Broadcom/Marvell product announcements indicating vertical integration.